Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Migraine Satellite symposium Article A spotlight on time in migraine management Schizophrenia Congress highlights Article Can people with ultra-high risk of psychosis benefit from cognitive remediation? Migraine Satellite symposium Article Assessing patient disability is vital for successful treatment of migraine Migraine Satellite symposium Article Individualizing migraine therapy — the right treatment at the right time for the right patient